Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-05-04

Clinical Trial Update: Bridging Study for Killed Oral Cholera Vaccine in Ethiopia [Phase 4]

View source ↗

Summary

A Phase 4 bridging study of a killed oral cholera vaccine conducted in Ethiopia has completed. The study evaluated safety and immunogenicity in the target popul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Killed oral cholera vaccine (inactivated) (inactivated Vibrio cholerae vaccine)

Snippet

Sponsor: International Vaccine Institute | Conditions: Vibrio Cholerae, Cholera | Phase 4 | Status: COMPLETED